Tamoxifen
| CAS No. | 10540-29-1 | Cat. No. | BCP33248 |
| Name | Tamoxifen | ||
| Synonyms | ICI 46474; ICI-46474; ICI46474; (Z)-Tamoxifen; trans-Tamoxifen; | ||
| Formula | C26H29NO | M. Wt | 371.51 |
| Description | Tamoxifen is a selective estrogen receptor modulator (SERM) and antagonist of ER action in breast tissue and breast cancer cells. It is reported to be effective in the treatment of early breast cancer to prevent tumor growth. Importantly, tamoxifen has been reported to act as an ER agonist in bone and blood vessels, helping to minimize osteoporosis and reduce the risk of cardiovascular disease in post-menopausal women. Also, tamoxifen is a partial ER agonist in uterine tissues and is reported to increase the risk of endometrial carcinoma. | ||
| Pathways | Protease/Metabolic Enzyme Cell Cycle/DNA Damage Hormone Pathay | ||
| Targets | Estrogen Receptor HSP | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.